Similar articles

• Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.

  Grodstein F, Manson JE, Stampfer MJ. Grodstein F, et al. J Womens Health (Larchmt). 2006 Jan-Feb;15(1):35-44. doi: 10.1089/jwh.2006.15.35. J Womens Health (Larchmt). 2006. PMID: 16417416
• Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.

  Banks E, Canfell K. Banks E, et al. Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25. Am J Epidemiol. 2009. PMID: 19468078
• Hormone therapy and coronary heart disease in young women.

  Weiner MG, Barnhart K, Xie D, Tannen RL. Weiner MG, et al. Menopause. 2008 Jan-Feb;15(1):86-93. doi: 10.1097/gme.0b013e3180413e45. Menopause. 2008. PMID: 17502840
• [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data].

  Gaspard U. Gaspard U. J Gynecol Obstet Biol Reprod (Paris). 2008 Jun;37(4):340-5. doi: 10.1016/j.jgyn.2007.12.003. Epub 2008 Feb 4. J Gynecol Obstet Biol Reprod (Paris). 2008. PMID: 18249506 Review. French.
• Menopause and HRT--the state of the art in Europe.

  Barlow DH. Barlow DH. Maturitas. 2005 May 16;51(1):40-7. doi: 10.1016/j.maturitas.2005.02.013. Maturitas. 2005. PMID: 15883108 Review.